yutrepia

Generic: treprostinil

Labeler: liquidia technologies, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name yutrepia
Generic Name treprostinil
Labeler liquidia technologies, inc.
Dosage Form CAPSULE
Routes
RESPIRATORY (INHALATION)
Active Ingredients

treprostinil sodium 53 ug/1

Manufacturer
Liquidia Technologies, Inc.

Identifiers & Regulatory

Product NDC 72964-012
Product ID 72964-012_92c4515d-7de1-4bde-9ee9-f350696ba98d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA213005
Listing Expiration 2026-12-31
Marketing Start 2025-05-23

Pharmacologic Class

Classes
prostacycline vasodilator [epc] prostaglandins i [cs] vasodilation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72964012
Hyphenated Format 72964-012

Supplemental Identifiers

RxCUI
2714659 2714664 2714666 2714668 2714670 2714672 2714674 2714676
UNII
7JZ75N2NT6

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name yutrepia (source: ndc)
Generic Name treprostinil (source: ndc)
Application Number NDA213005 (source: ndc)
Routes
RESPIRATORY (INHALATION)
source: ndc

Resolved Composition

Strengths
  • 53 ug/1
source: ndc
Packaging
  • 7 BLISTER PACK in 1 CARTON (72964-012-01) / 4 CAPSULE in 1 BLISTER PACK / 1 CAPSULE in 1 CAPSULE
source: ndc

Packages (1)

72964-012-01 7 BLISTER PACK in 1 CARTON (72964-012-01) / 4 CAPSULE in 1 BLISTER PACK / 1 CAPSULE in 1 CAPSULE

Ingredients (1)

treprostinil sodium (53 ug/1)

Linked Drug Pages (1)

Yutrepia ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "92c4515d-7de1-4bde-9ee9-f350696ba98d", "openfda": {"unii": ["7JZ75N2NT6"], "rxcui": ["2714659", "2714664", "2714666", "2714668", "2714670", "2714672", "2714674", "2714676"], "spl_set_id": ["e8f6d534-115c-440e-bdbb-b443a29bb468"], "manufacturer_name": ["Liquidia Technologies, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "7 BLISTER PACK in 1 CARTON (72964-012-01)  / 4 CAPSULE in 1 BLISTER PACK / 1 CAPSULE in 1 CAPSULE", "package_ndc": "72964-012-01", "marketing_start_date": "20250523"}], "brand_name": "Yutrepia", "product_id": "72964-012_92c4515d-7de1-4bde-9ee9-f350696ba98d", "dosage_form": "CAPSULE", "pharm_class": ["Prostacycline Vasodilator [EPC]", "Prostaglandins I [CS]", "Vasodilation [PE]"], "product_ndc": "72964-012", "generic_name": "treprostinil", "labeler_name": "Liquidia Technologies, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Yutrepia", "active_ingredients": [{"name": "TREPROSTINIL SODIUM", "strength": "53 ug/1"}], "application_number": "NDA213005", "marketing_category": "NDA", "marketing_start_date": "20250523", "listing_expiration_date": "20261231"}